REUNION NEUROSCIENCE INC (REUN) Stock Overview
USA - NASDAQ:REUN - CA76134G1037 - Common Stock
REUN Key Statistics, Chart & Performance
The current stock price of REUN is 1.12 USD. In the past month the price decreased by -0.88%.
REUN Latest News, Press Relases and Analysis
REUN Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 21.64 | 404.77B | ||
| AMGN | AMGEN INC | 13.47 | 158.20B | ||
| GILD | GILEAD SCIENCES INC | 15.31 | 147.01B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 24.33 | 105.69B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 61.52B | ||
| REGN | REGENERON PHARMACEUTICALS | 12.55 | 60.69B | ||
| ARGX | ARGENX SE - ADR | 87.7 | 49.75B | ||
| ONC | BEONE MEDICINES LTD-ADR | 5.2 | 35.25B | ||
| INSM | INSMED INC | N/A | 34.11B | ||
| BNTX | BIONTECH SE-ADR | N/A | 24.67B | ||
| NTRA | NATERA INC | N/A | 23.72B | ||
| BIIB | BIOGEN INC | 9.08 | 21.30B |
Related stock screener links
About REUN
Company Profile
Reunion Neuroscience, Inc. operates drug discovery and development business. The company is headquartered in Toronto, Ontario. The company went IPO on 2009-02-18. The firm is developing the advancement of synthetic molecules targeting serotonin 5HT2A receptors. The Company’s products include RE104 and RE200. The Company’s lead asset, RE-104, which is a psychedelic drug being developed for post-partum and treatment resistant depression as a potential fast-acting antidepressant with durable efficacy. The RE104 as a potentially fast-acting treatment for the key indications of postpartum and treatment resistant depression. The firm is developing the RE200 series, which includes compounds with potential for more selective serotonin receptor activity with reduced psych activity for potential use in more chronic treatment paradigms and indications. The firm is focused on the research and development of its RE200 molecule group.
Company Info
REUNION NEUROSCIENCE INC
30 Duncan Street, Suite 401
TORONTO ONTARIO CA
Employees: 0
Phone: 18338331967.0
REUNION NEUROSCIENCE INC / REUN FAQ
What is the stock price of REUNION NEUROSCIENCE INC today?
The current stock price of REUN is 1.12 USD. The price decreased by -0.88% in the last trading session.
What is the ticker symbol for REUNION NEUROSCIENCE INC stock?
The exchange symbol of REUNION NEUROSCIENCE INC is REUN and it is listed on the Nasdaq exchange.
On which exchange is REUN stock listed?
REUN stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for REUNION NEUROSCIENCE INC stock?
8 analysts have analysed REUN and the average price target is 130.02 USD. This implies a price increase of 11508.75% is expected in the next year compared to the current price of 1.12. Check the REUNION NEUROSCIENCE INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is REUNION NEUROSCIENCE INC worth?
REUNION NEUROSCIENCE INC (REUN) has a market capitalization of 13.12M USD. This makes REUN a Nano Cap stock.
How many employees does REUNION NEUROSCIENCE INC have?
REUNION NEUROSCIENCE INC (REUN) currently has 0 employees.
What are the support and resistance levels for REUNION NEUROSCIENCE INC (REUN) stock?
REUNION NEUROSCIENCE INC (REUN) has a support level at 1.12 and a resistance level at 1.13. Check the full technical report for a detailed analysis of REUN support and resistance levels.
Is REUNION NEUROSCIENCE INC (REUN) expected to grow?
The Revenue of REUNION NEUROSCIENCE INC (REUN) is expected to decline by -100% in the next year. Check the estimates tab for more information on the REUN EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy REUNION NEUROSCIENCE INC (REUN) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of REUN, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of REUN, evaluating the profitability, health, valuation and growth aspects
- REUNION NEUROSCIENCE INC (REUN) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- REUNION NEUROSCIENCE INC (REUN) Sales and EPS estimates to see what analysts future expectations are.
- REUNION NEUROSCIENCE INC (REUN) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- REUNION NEUROSCIENCE INC (REUN) Insider and Institutional Ownership to learn about the owners and their transactions.
- REUNION NEUROSCIENCE INC (REUN) Stock Chart to make your own analysis
- REUNION NEUROSCIENCE INC (REUN) Latest news and press-releases to stay up to date.
Does REUNION NEUROSCIENCE INC (REUN) stock pay dividends?
REUN does not pay a dividend.
What is the Price/Earnings (PE) ratio of REUNION NEUROSCIENCE INC (REUN)?
REUNION NEUROSCIENCE INC (REUN) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.33).
REUN Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to REUN.
REUN Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to REUN. The financial health of REUN is average, but there are quite some concerns on its profitability.
REUN Financial Highlights
Over the last trailing twelve months REUN reported a non-GAAP Earnings per Share(EPS) of -2.33. The EPS increased by 86.96% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | 0 |
REUN Forecast & Estimates
8 analysts have analysed REUN and the average price target is 130.02 USD. This implies a price increase of 11508.75% is expected in the next year compared to the current price of 1.12.
For the next year, analysts expect an EPS growth of 47.21% and a revenue growth -100% for REUN